Cargando…

Coronary flow reserve is impaired in patients with obstructive sleep apnea

STUDY OBJECTIVES: Obstructive sleep apnea (OSA) is common in adult populations. Accumulating data indicate that it is independently associated with a variety of cardiovascular diseases and has prognostic importance in affected cases. In this study, we aimed to evaluate coronary flow reserve (CFR) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Bozbas, Serife Savas, Eroglu, Serpil, Ozyurek, Berna Akinci, Eyuboglu, Fusun Oner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656946/
https://www.ncbi.nlm.nih.gov/pubmed/29118860
http://dx.doi.org/10.4103/atm.ATM_195_16
_version_ 1783273792973307904
author Bozbas, Serife Savas
Eroglu, Serpil
Ozyurek, Berna Akinci
Eyuboglu, Fusun Oner
author_facet Bozbas, Serife Savas
Eroglu, Serpil
Ozyurek, Berna Akinci
Eyuboglu, Fusun Oner
author_sort Bozbas, Serife Savas
collection PubMed
description STUDY OBJECTIVES: Obstructive sleep apnea (OSA) is common in adult populations. Accumulating data indicate that it is independently associated with a variety of cardiovascular diseases and has prognostic importance in affected cases. In this study, we aimed to evaluate coronary flow reserve (CFR) in patients with OSA and controls. METHODS: Sixty-one patients undergoing an overnight polysomnography were enrolled in this study. Patients with an apnea–hypopnea index (AHI) >5 were accepted as OSA group (n = 45) and those with an AHI <5 were taken as controls (n = 16). Using Doppler echocardiography at baseline and following dipyridamole infusion, coronary peak flow velocities were obtained. CFR was calculated as the ratio of peak diastolic flow to baseline diastolic flow. A CFR value <2 was accepted as impaired coronary microvascular function. RESULTS: The mean age was 50.8 ± 10.8 years, of which 16 (26.2%) were female. Both groups had similar features with regard to demographic and clinical variables. The mean value of CFR was significantly lower in patients with OSA compared to those controls (2.24 ± 0.46 vs. 2.74 ± 0.62, respectively, P = 0.001). An abnormal CFR value was observed in 12 (26.7%) patients with OSA and in 1 (6.3%) participant in control group. CONCLUSIONS: The findings of this study indicate that CFR, an indicator of coronary microvascular function, is significantly impaired in patients with OSA. Coronary microvascular function, an early sign of atherosclerosis, can be evaluated noninvasively in these patients might be used as a predictor of cardiovascular risk.
format Online
Article
Text
id pubmed-5656946
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-56569462017-11-08 Coronary flow reserve is impaired in patients with obstructive sleep apnea Bozbas, Serife Savas Eroglu, Serpil Ozyurek, Berna Akinci Eyuboglu, Fusun Oner Ann Thorac Med Original Article STUDY OBJECTIVES: Obstructive sleep apnea (OSA) is common in adult populations. Accumulating data indicate that it is independently associated with a variety of cardiovascular diseases and has prognostic importance in affected cases. In this study, we aimed to evaluate coronary flow reserve (CFR) in patients with OSA and controls. METHODS: Sixty-one patients undergoing an overnight polysomnography were enrolled in this study. Patients with an apnea–hypopnea index (AHI) >5 were accepted as OSA group (n = 45) and those with an AHI <5 were taken as controls (n = 16). Using Doppler echocardiography at baseline and following dipyridamole infusion, coronary peak flow velocities were obtained. CFR was calculated as the ratio of peak diastolic flow to baseline diastolic flow. A CFR value <2 was accepted as impaired coronary microvascular function. RESULTS: The mean age was 50.8 ± 10.8 years, of which 16 (26.2%) were female. Both groups had similar features with regard to demographic and clinical variables. The mean value of CFR was significantly lower in patients with OSA compared to those controls (2.24 ± 0.46 vs. 2.74 ± 0.62, respectively, P = 0.001). An abnormal CFR value was observed in 12 (26.7%) patients with OSA and in 1 (6.3%) participant in control group. CONCLUSIONS: The findings of this study indicate that CFR, an indicator of coronary microvascular function, is significantly impaired in patients with OSA. Coronary microvascular function, an early sign of atherosclerosis, can be evaluated noninvasively in these patients might be used as a predictor of cardiovascular risk. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5656946/ /pubmed/29118860 http://dx.doi.org/10.4103/atm.ATM_195_16 Text en Copyright: © 2017 Annals of Thoracic Medicine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Bozbas, Serife Savas
Eroglu, Serpil
Ozyurek, Berna Akinci
Eyuboglu, Fusun Oner
Coronary flow reserve is impaired in patients with obstructive sleep apnea
title Coronary flow reserve is impaired in patients with obstructive sleep apnea
title_full Coronary flow reserve is impaired in patients with obstructive sleep apnea
title_fullStr Coronary flow reserve is impaired in patients with obstructive sleep apnea
title_full_unstemmed Coronary flow reserve is impaired in patients with obstructive sleep apnea
title_short Coronary flow reserve is impaired in patients with obstructive sleep apnea
title_sort coronary flow reserve is impaired in patients with obstructive sleep apnea
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656946/
https://www.ncbi.nlm.nih.gov/pubmed/29118860
http://dx.doi.org/10.4103/atm.ATM_195_16
work_keys_str_mv AT bozbasserifesavas coronaryflowreserveisimpairedinpatientswithobstructivesleepapnea
AT erogluserpil coronaryflowreserveisimpairedinpatientswithobstructivesleepapnea
AT ozyurekbernaakinci coronaryflowreserveisimpairedinpatientswithobstructivesleepapnea
AT eyuboglufusunoner coronaryflowreserveisimpairedinpatientswithobstructivesleepapnea